HealthQuill Drugs
Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients with metastatic uveal melanoma, giving the Delaware-based firm $60 million fund access.
Drugs Health Pharma

Delcath Systems gets FDA nod for Hepzato Kit to treat uveal melanoma

HQ Team August 16, 2023: Delcath Systems Inc., has been granted an FDA nod for its Hepzato Kit, a liver-directed treatment for patients.

Read More
Three people have died and 1,020 newly confirmed cases of mpox were reported globally to the WHO during the last 21 days, according to a statement.
Drugs Health Pharma

Mpox virus continues to spread, driven by China’s community transmission 

HQ Team August 15, 2023: Three people have died and 1,020 newly confirmed cases of mpox were reported globally to the WHO during.

Read More
The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that affects plasma cells made in the bone marrow, according to a company statement.
Drugs Health Pharma

US regulator approves Pfizer’s Elrexfio to treat multiple myeloma

HQ Team August 15, 2023: The USFDA has granted accelerated approval for Pfizer Inc’s Elrexfio to treat incurable blood cancer, multiple myeloma, that.

Read More
Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which in future can fight cancer and diabetes.
Drugs Health Pharma

Biomedical engineers create ML model to turn genes on and off

HQ Team August 14, 2023: Biomedical engineers at Johns Hopkins have developed a machine-learning model, which can turn on genes —an innovation which.

Read More
At least 327 people have died in Bangladesh from January 1 to August 7 due to dengue, with the density of mosquitoes and potential hotspots being the highest in five years.
Drugs Health Pharma

Dengue claims 327 lives in Bangladesh, cases rising

HQ Team August 12, 2023: At least 327 people have died in Bangladesh from January 1 to August 7 due to dengue, with.

Read More
The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat multiple myeloma.
Drugs Health Pharma

USFDA green lights Janssen’s Talvey to treat multiple myeloma

HQ Team August 11, 2023: The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat.

Read More
The UK’s competition regulator, Competition and Markets Authority has provisionally cleared UnitedHealth’s proposed £1.2bn ($1.6 billion) plan to buy EMIS after a probe by an independent panel.
Drugs Health Pharma

UK’s antitrust body provisionally clears $1.6b UnitedHealth-EMIS merger

HQ Team August 11, 2023: The UK’s competition regulator, Competition and Markets Authority has provisionally cleared UnitedHealth’s proposed £1.2bn ($1.6 billion) plan to.

Read More
Sweden’s Getinge Group is recalling its  cardiosave hybrid and rescue intra-aortic balloon pumps after the FDA initiated a most serious recall, Class 1.
Drugs Health Pharma

Getinge Group recalls intra-aortic pumps due to faulty power system

HQ Team August 11, 2023: Sweden’s Getinge Group is recalling its cardiosave hybrid and rescue intra-aortic balloon pumps after the FDA initiated a.

Read More
A gold-plated nanoscale tattoo-like electronics array can be inserted into live human cells, that in the future can diagnose health problems early, according to researchers at Johns Hopkins University.
Drugs Health Pharma

Tattoo-like electronics cell array may detect diseases early 

HQ Team August 10, 2023: A gold-plated nanoscale tattoo-like electronics array can be inserted into live human cells, that in the future can.

Read More
The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with genetic changes that are predicted or known to affect virus characteristics, such as transmissibility, virulence, antibody evasion, susceptibility to therapeutics and detectability.
Drugs Health Pharma

WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise

HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.

Read More